Genomic Valley Biotech Ltd. - Research Center
539206 GVBL Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
0.36 |
0.13 |
1.05 |
0.02 |
0.05 |
Operating profit |
0.27 |
0.05 |
-0.09 |
-0.35 |
-0.03 |
Interest |
- |
- |
- |
- |
0.04 |
Gross profit |
0.28 |
0.05 |
-0.07 |
-0.26 |
-0.07 |
EPS (Rs) |
0.90 |
0.16 |
1.70 |
0.51 |
-0.54 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
0.01 |
- |
0.02 |
0.08 |
- |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.05 |
0.03 |
0.10 |
0.10 |
0.04 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.04 |
0.05 |
1.05 |
0.27 |
0.03 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
0.02 |
-0.01 |
0.09 |
Taxation |
- |
- |
- |
0.01 |
- |
Net profit / loss |
0.28 |
0.05 |
0.52 |
0.16 |
-0.17 |
Extra ordinary item |
- |
- |
0.60 |
0.42 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
3.05 |
3.05 |
3.05 |
3.05 |
3.05 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
74.63 |
38.93 |
-8.49 |
-1416.94 |
-63.74 |
GPM (%) |
75.13 |
39.65 |
-6.22 |
-243.80 |
- |
NPM (%) |
74.86 |
39.21 |
48.36 |
144.17 |
- |